Legal Representation
Attorney
Tricia L. Schulz
USPTO Deadlines
Application History
10 events| Date | Code | Type | Description |
|---|---|---|---|
| Aug 12, 2022 | ABN2 | O | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE |
| Aug 12, 2022 | MAB2 | O | ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND |
| Aug 12, 2022 | MAB2 | E | ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND |
| Jan 26, 2022 | CNRT | R | NON-FINAL ACTION WRITTEN |
| Jan 26, 2022 | GNRT | F | NON-FINAL ACTION E-MAILED |
| Jan 26, 2022 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Jan 10, 2022 | DOCK | D | ASSIGNED TO EXAMINER |
| Dec 8, 2021 | ASGN | I | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP |
| Aug 23, 2021 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| May 31, 2021 | NWAP | I | NEW APPLICATION ENTERED |
Detailed Classifications
Class 005
Biopharmaceutical preparations for the prevention and treatment of mitochondrial, cardiovascular, renal, ophthalmic, neurologic, myopathic and metabolic diseases and disorders; biological preparations for the prevention and treatment of cellular abnormalities
First Use Anywhere:
0
First Use in Commerce:
0
Class 042
Scientific research and development; biopharmaceutical research, development and testing; medical and scientific research in the mitochondrial, cardiovascular, renal, ophthalmic, neurologic, myopathic and metabolic system fields
First Use Anywhere:
0
First Use in Commerce:
0
Classification
International Classes
005
042